Haemonetics Corp. HAE

NYS: HAE | ISIN: US4050241003   11/09/2026
102,69 USD (+1,61%)
(+1,61%)   11/09/2026

6 augustus 2026 · Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website · Persbericht

3 augustus 2026 · New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths · Persbericht

28 juli 2026 · Martin Madaus Elected to Haemonetics Board of Directors · Persbericht

8 juli 2026 · Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026 · Persbericht

5 juni 2026 · Haemonetics Updates Financial Reporting Segments · Persbericht

2 juni 2026 · Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference · Persbericht

7 mei 2026 · Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website · Persbericht

5 mei 2026 · Haemonetics to Present at Bank of America 2026 Healthcare Conference · Persbericht

24 april 2026 · New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures · Persbericht

1 april 2026 · Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 · Persbericht

30 maart 2026 · Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System · Persbericht

23 februari 2026 · Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology · Persbericht

20 februari 2026 · Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference · Persbericht

5 februari 2026 · Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website · Persbericht

9 januari 2026 · Haemonetics Acquires Vivasure Medical Limited · Persbericht

8 januari 2026 · Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026 · Persbericht

2 januari 2026 · Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference · Persbericht

6 november 2025 · Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website · Persbericht

9 oktober 2025 · Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025 · Persbericht

7 augustus 2025 · Haemonetics 1st Quarter Fiscal Year 2026 Earnings Release Available on Investor Relations Website · Persbericht

Mijn selecties